The overexpression of MIF has been demonstrated in the progression of multiple cancers, such as ovarian cancer (Krockenberger et al., 2012), hepatocellular carcinoma (Wang et al., 2014), gastric cancer (He et al., 2006), and other malignant cancers. Here, MIF is linked to hepatocellular carcinoma.